ArticleBMC women's health2025
Ovarian adenomyoma: a case report.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionOvarian adenomyoma is a rare gynecological tumor with a high misdiagnosis rate, leading many patients to undergo unnecessary surgeries that may affect fertility. Menstrual abdominal pain is the most common symptom, and auxiliary examinations often cannot clarify its nature. It often relies on intraoperative diagnosis, and surgical resection can achieve good therapeutic effects. CASE PRESENTATION: A 50-year-old woman presented with lower abdominal pain during her menstrual period for the past two months. She had a previous medical history of uterine adenomyomectomy, ovarian cystectomy, and a cesarean section. Ultrasound revealed a 5.7 × 3.8 × 4.3 cm mass on the posterior wall of the uterus, a 9.9 × 5.6 × 8.2 cm hypoechoic mass in the right posterior part of the uterus, and a 2.8 × 2.2 × 2.7 cm anechoic mass in the left ovary. CA125 (Carbohydrate antigen 125) 191.80U/ml (0-30). MRI (magnetic resonance imaging) imaging confirmed a 7.9 × 6.2 × 7.2 cm fibroid on the right posterior wall of the uterus. Consider partial degeneration of multiple uterine fibroids and benign cystic degeneration in the lower left abdomen. Surgical resection was performed smoothly, and the diagnosis was confirmed by postoperative pathology.
conclusionOvarian adenomyoma is a rare benign gynecologic tumour with a high rate of misdiagnosis. When a patient presents with recent lower abdominal pain or dysmenorrhea, a history of endometriosis or myomectomy, and MRI findings showing irregular bleeding patterns in a pelvic mass, the possibility of extrauterine adenomyosis should be considered. Minimally invasive treatment options, such as single-port laparoscopy or vaginal dissection, may offer advantages, but caution should be exercised due to the potential for malignant tumors. Preserving fertility is something worth exploring. We hope to provide warnings to more gynaecologists and reduce misdiagnosis and unnecessary treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.